130 related articles for article (PubMed ID: 7378171)
1. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
Kojo H; Shigi Y; Nishida M
J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of fosmidomycin on chromosomic and plasmid-determined fosfomycin-resistant strains.
Mendez FJ; Alvarez AA; Mendoza MC; Hardisson C
Chemioterapia; 1985 Apr; 4(2):170-5. PubMed ID: 4006006
[TBL] [Abstract][Full Text] [Related]
4. Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
Neu HC; Kamimura T
Antimicrob Agents Chemother; 1982 Oct; 22(4):560-3. PubMed ID: 7181471
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
Neu HC; Kamimura T
Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
[TBL] [Abstract][Full Text] [Related]
6. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
Yokota Y; Murakawa T; Nishida M
J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
[TBL] [Abstract][Full Text] [Related]
7. Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289.
Okuhara M; Kuroda Y; Goto T; Okamoto M; Terano H; Kohsaka M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1980 Jan; 33(1):24-8. PubMed ID: 6768705
[TBL] [Abstract][Full Text] [Related]
8. Fosfomycin resistance plasmids do not affect fosfomycin transport into Escherichia coli.
León J; García-Lobo JM; Ortiz JM
Antimicrob Agents Chemother; 1982 Apr; 21(4):608-12. PubMed ID: 7044304
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
Courtieu AL; Drugeon H; Billaudel S
Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
[TBL] [Abstract][Full Text] [Related]
10. Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K--12.
Tsuruoka T; Miyata A; Yamada Y
J Antibiot (Tokyo); 1978 Mar; 31(3):192-201. PubMed ID: 206529
[TBL] [Abstract][Full Text] [Related]
11. The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutants.
Drugeon HB; Courtieu AL
Chemotherapy; 1982; 28(5):345-50. PubMed ID: 7140421
[TBL] [Abstract][Full Text] [Related]
12. Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.
Falagas ME; Athanasaki F; Voulgaris GL; Triarides NA; Vardakas KZ
Int J Antimicrob Agents; 2019 Jan; 53(1):22-28. PubMed ID: 30268576
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of fosfomycin in vitro.
Forsgren A; Walder M
J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
[TBL] [Abstract][Full Text] [Related]
14. The action of fosfomycin on the growth of Pseudomonas aeruginosa.
Hardisson C; Llaneza J
Chemotherapy; 1977; 23 Suppl 1():37-44. PubMed ID: 401719
[TBL] [Abstract][Full Text] [Related]
15. [Antibiotics of the phosphonic acid group].
Poliak MS
Antibiot Med Biotekhnol; 1987 Jan; 32(1):66-75. PubMed ID: 3551820
[No Abstract] [Full Text] [Related]
16. Pseudomonas aeruginosa fosfomycin resistance mechanisms affect non-inherited fluoroquinolone tolerance.
De Groote VN; Fauvart M; Kint CI; Verstraeten N; Jans A; Cornelis P; Michiels J
J Med Microbiol; 2011 Mar; 60(Pt 3):329-336. PubMed ID: 21212150
[TBL] [Abstract][Full Text] [Related]
17. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
[TBL] [Abstract][Full Text] [Related]
19. Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization.
Okuhara M; Kuroda Y; Goto T; Okamoto M; Terano H; Kohsaka M; Aoki H; Imanaka H
J Antibiot (Tokyo); 1980 Jan; 33(1):13-7. PubMed ID: 6768704
[TBL] [Abstract][Full Text] [Related]
20. Interactions of fosfomycin with other antibiotics.
Daza R; Moreno-López M; Dámaso D
Chemotherapy; 1977; 23 Suppl 1():86-92. PubMed ID: 832546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
